Skip to main content
Clinical Trials/CTRI/2024/05/067554
CTRI/2024/05/067554
Not yet recruiting
未知

To Study the Psychological Impact, Associated Disorders and Treatment Options in Vitiligo

Department of Dermatology Government Medical College Baramulla0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
Department of Dermatology Government Medical College Baramulla
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Department of Dermatology Government Medical College Baramulla

Eligibility Criteria

Inclusion Criteria

  • 1\. All the patients diagnosed with Vitiligo of all age groups and of either sex visiting OPD of the Dermatology Department and who gave consent during the study period were included in this study.
  • 2\. Confirmed vitiligo diagnosis by a healthcare professional through clinical examination, dermoscopy, or biopsy (specific methodology may vary based on study design).
  • 3\. Consent to participate in the study procedures, including surveys, interviews, physical examinations, blood tests, or imaging studies (specific procedures depend on study focus).
  • 4\. No age or demographic restrictions unless studying specific populations (e.g., pregnant women, above 70 years).
  • 5\. Age of consent (e.g., 18\+) and ability to complete psychological assessments.
  • 6\. Diagnosis of a specific co\-occurring disorder confirmed through medical records or additional diagnostic procedures.
  • 7\. Specific disease type, severity, and age range suitable for the investigated treatment modality.

Exclusion Criteria

  • 1\. Patients not giving consent to participate in the study.
  • 2\. Mimicking Conditions: Presence of skin conditions that could mimic vitiligo (e.g., piebaldism, post\-inflammatory hypopigmentation).
  • 3\. Self\-Reported Vitiligo: Individuals lacking a professional diagnosis of vitiligo.
  • 4\. Cognitive/Psychiatric Conditions: Severe cognitive or psychiatric conditions that could significantly impact data collection or interpretation.
  • 5\. Medical Conditions: Presence of medical conditions that could confound study results or pose safety risks (e.g., chronic infections, certain medications).
  • 6\. Treatment Contraindications: Known contraindications to the specific treatment being investigated (e.g., allergies, specific medical conditions).
  • 7\. Ongoing Trials: Participation in other clinical trials that could interfere with study results.
  • 8\. Individuals with language barriers that impede effective communication may be excluded.
  • 9\. Pregnant or breastfeeding women may be excluded depending on the specific treatment safety data.
  • 10\. Uncertain diagnoses of vitiligo or co\-occurring disorders may lead to exclusion to ensure study accuracy.

Outcomes

Primary Outcomes

Not specified

Similar Trials